Metabolic effects of mulberry leaves: Exploring potential benefits in type 2 diabetes and hyperuricemia

A. Hunyadi, E. Liktor-Busa, A. Márki, A. Martins, N. Jedlinszki, T. J. Hsieh, M. Báthori, J. Hohmann, I. Zupkó

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The leaves of Morus alba L. have a long history in Traditional Chinese Medicine and also became valued by the ethnopharmacology of many other cultures. The worldwide known antidiabetic use of the drug has been suggested to arise from a complex combination effect of various constituents. Moreover, the drug is also a potential antihyperuricemic agent. Considering that type 2 diabetes and hyperuricemia are vice-versa in each other's important risk factors, the use of mulberry originated phytotherapeutics might provide an excellent option for the prevention and/or treatment of both conditions. Here we report a series of relevant in vitro and in vivo studies on the bioactivity of an extract of mulberry leaves and its fractions obtained by a stepwise gradient on silica gel. In vivo antihyperglycemic and antihyperuricemic activity, plasma antioxidant status, as well as in vitro glucose consumption by adipocytes in the presence or absence of insulin, xanthine oxidase inhibition, free radical scavenging activity, and inhibition of lipid peroxidation were tested. Known bioactive constituents of M. alba (chlorogenic acid, rutin, isoquercitrin, and loliolide) were identified and quantified from the HPLC-DAD fingerprint chromatograms. Iminosugar contents were investigated by MS/MS, 1-deoxynojirimycin was quantified, and amounts of 2-O-alpha-D-galactopyranosyl-1-deoxynojirimicin and fagomine were additionally estimated.

Original languageEnglish
Article number948627
JournalEvidence-based Complementary and Alternative Medicine
Volume2013
DOIs
Publication statusPublished - 2013

Fingerprint

Morus
Hyperuricemia
Gout Suppressants
Type 2 Diabetes Mellitus
Hypoglycemic Agents
Ethnopharmacology
1-Deoxynojirimycin
Chlorogenic Acid
Rutin
Xanthine Oxidase
Silica Gel
Chinese Traditional Medicine
Dermatoglyphics
Adipocytes
Lipid Peroxidation
Free Radicals
Antioxidants
History
High Pressure Liquid Chromatography
Insulin

ASJC Scopus subject areas

  • Complementary and alternative medicine

Cite this

Metabolic effects of mulberry leaves : Exploring potential benefits in type 2 diabetes and hyperuricemia. / Hunyadi, A.; Liktor-Busa, E.; Márki, A.; Martins, A.; Jedlinszki, N.; Hsieh, T. J.; Báthori, M.; Hohmann, J.; Zupkó, I.

In: Evidence-based Complementary and Alternative Medicine, Vol. 2013, 948627, 2013.

Research output: Contribution to journalArticle

@article{840f2912f0eb44b8a848988b67a07d13,
title = "Metabolic effects of mulberry leaves: Exploring potential benefits in type 2 diabetes and hyperuricemia",
abstract = "The leaves of Morus alba L. have a long history in Traditional Chinese Medicine and also became valued by the ethnopharmacology of many other cultures. The worldwide known antidiabetic use of the drug has been suggested to arise from a complex combination effect of various constituents. Moreover, the drug is also a potential antihyperuricemic agent. Considering that type 2 diabetes and hyperuricemia are vice-versa in each other's important risk factors, the use of mulberry originated phytotherapeutics might provide an excellent option for the prevention and/or treatment of both conditions. Here we report a series of relevant in vitro and in vivo studies on the bioactivity of an extract of mulberry leaves and its fractions obtained by a stepwise gradient on silica gel. In vivo antihyperglycemic and antihyperuricemic activity, plasma antioxidant status, as well as in vitro glucose consumption by adipocytes in the presence or absence of insulin, xanthine oxidase inhibition, free radical scavenging activity, and inhibition of lipid peroxidation were tested. Known bioactive constituents of M. alba (chlorogenic acid, rutin, isoquercitrin, and loliolide) were identified and quantified from the HPLC-DAD fingerprint chromatograms. Iminosugar contents were investigated by MS/MS, 1-deoxynojirimycin was quantified, and amounts of 2-O-alpha-D-galactopyranosyl-1-deoxynojirimicin and fagomine were additionally estimated.",
author = "A. Hunyadi and E. Liktor-Busa and A. M{\'a}rki and A. Martins and N. Jedlinszki and Hsieh, {T. J.} and M. B{\'a}thori and J. Hohmann and I. Zupk{\'o}",
year = "2013",
doi = "10.1155/2013/948627",
language = "English",
volume = "2013",
journal = "Evidence-based Complementary and Alternative Medicine",
issn = "1741-427X",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Metabolic effects of mulberry leaves

T2 - Exploring potential benefits in type 2 diabetes and hyperuricemia

AU - Hunyadi, A.

AU - Liktor-Busa, E.

AU - Márki, A.

AU - Martins, A.

AU - Jedlinszki, N.

AU - Hsieh, T. J.

AU - Báthori, M.

AU - Hohmann, J.

AU - Zupkó, I.

PY - 2013

Y1 - 2013

N2 - The leaves of Morus alba L. have a long history in Traditional Chinese Medicine and also became valued by the ethnopharmacology of many other cultures. The worldwide known antidiabetic use of the drug has been suggested to arise from a complex combination effect of various constituents. Moreover, the drug is also a potential antihyperuricemic agent. Considering that type 2 diabetes and hyperuricemia are vice-versa in each other's important risk factors, the use of mulberry originated phytotherapeutics might provide an excellent option for the prevention and/or treatment of both conditions. Here we report a series of relevant in vitro and in vivo studies on the bioactivity of an extract of mulberry leaves and its fractions obtained by a stepwise gradient on silica gel. In vivo antihyperglycemic and antihyperuricemic activity, plasma antioxidant status, as well as in vitro glucose consumption by adipocytes in the presence or absence of insulin, xanthine oxidase inhibition, free radical scavenging activity, and inhibition of lipid peroxidation were tested. Known bioactive constituents of M. alba (chlorogenic acid, rutin, isoquercitrin, and loliolide) were identified and quantified from the HPLC-DAD fingerprint chromatograms. Iminosugar contents were investigated by MS/MS, 1-deoxynojirimycin was quantified, and amounts of 2-O-alpha-D-galactopyranosyl-1-deoxynojirimicin and fagomine were additionally estimated.

AB - The leaves of Morus alba L. have a long history in Traditional Chinese Medicine and also became valued by the ethnopharmacology of many other cultures. The worldwide known antidiabetic use of the drug has been suggested to arise from a complex combination effect of various constituents. Moreover, the drug is also a potential antihyperuricemic agent. Considering that type 2 diabetes and hyperuricemia are vice-versa in each other's important risk factors, the use of mulberry originated phytotherapeutics might provide an excellent option for the prevention and/or treatment of both conditions. Here we report a series of relevant in vitro and in vivo studies on the bioactivity of an extract of mulberry leaves and its fractions obtained by a stepwise gradient on silica gel. In vivo antihyperglycemic and antihyperuricemic activity, plasma antioxidant status, as well as in vitro glucose consumption by adipocytes in the presence or absence of insulin, xanthine oxidase inhibition, free radical scavenging activity, and inhibition of lipid peroxidation were tested. Known bioactive constituents of M. alba (chlorogenic acid, rutin, isoquercitrin, and loliolide) were identified and quantified from the HPLC-DAD fingerprint chromatograms. Iminosugar contents were investigated by MS/MS, 1-deoxynojirimycin was quantified, and amounts of 2-O-alpha-D-galactopyranosyl-1-deoxynojirimicin and fagomine were additionally estimated.

UR - http://www.scopus.com/inward/record.url?scp=84893757435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893757435&partnerID=8YFLogxK

U2 - 10.1155/2013/948627

DO - 10.1155/2013/948627

M3 - Article

AN - SCOPUS:84893757435

VL - 2013

JO - Evidence-based Complementary and Alternative Medicine

JF - Evidence-based Complementary and Alternative Medicine

SN - 1741-427X

M1 - 948627

ER -